Chemical Structure (Epsolay 01)
Epsolay Cream
Product Images NDC 51862-772
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Epsolay (NDC 51862-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Epsolay 02)
This text shows a table comparing the success rate (%) of IGA (Investigator's Global Assessment) between a vehicle cream and Epsolay over a 12-week period. The data indicates the success rates at different time points during the study.*
Figure 2 (Epsolay 03)
Figure 3 (Epsolay 04)
This text provides information about the mean change in inflammatory lesions over 12 weeks, comparing a vehicle cream with Epsolay. The data includes the baseline and measurements at 4 and 12 weeks.*
Figure 4 (Epsolay 05)
Principal Display Panel (30 g Bottle Carton)
This is a description of EPSOLAY cream, containing 5% benzoyl peroxide, distributed by Mayne Pharma. The cream is for topical use only and should not be used for ophthalmic or oral purposes. Each gram of the cream contains 50 mg (5%) of benzoyl peroxide. It is advisable to store the cream at 68°F to 77°F (20°C to 25°C), away from children, and avoid freezing it. Unused portions should be discarded after 60 days from the first use due to the potential for bleaching colored fabric or hair.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
